229 related articles for article (PubMed ID: 26904699)
21. Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis.
Feng X; Dong K; Pham D; Pence S; Inciardi J; Bhutada NS
J Clin Pharm Ther; 2013 Aug; 38(4):301-8. PubMed ID: 23550846
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous Tumor Lysis Syndrome in Diffuse Large B-cell Lymphoma: Early Diagnosis and Management.
Gangireddy M; Shrimanker I; Nookala VK; Peroutka KA
Cureus; 2019 May; 11(5):e4679. PubMed ID: 31328070
[TBL] [Abstract][Full Text] [Related]
23. [Rasburicase versus allopurinol in the treatment of hyperuricaemia in tumour lysis syndrome].
Tatay VS; Castilla JD; Ponce JM; Hurtado JM; Cantero E; Abril ML
An Pediatr (Barc); 2010 Feb; 72(2):103-10. PubMed ID: 20022572
[TBL] [Abstract][Full Text] [Related]
24. Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer.
Cheuk DK; Chiang AK; Chan GC; Ha SY
Cochrane Database Syst Rev; 2010 Jun; (6):CD006945. PubMed ID: 20556770
[TBL] [Abstract][Full Text] [Related]
25. Rasburicase for the treatment of tumor lysis in hematological malignancies.
Malaguarnera G; Giordano M; Malaguarnera M
Expert Rev Hematol; 2012 Feb; 5(1):27-38. PubMed ID: 22272702
[TBL] [Abstract][Full Text] [Related]
26. Use of single-dose rasburicase in an obese female.
Arnold TM; Reuter JP; Delman BS; Shanholtz CB
Ann Pharmacother; 2004 Sep; 38(9):1428-31. PubMed ID: 15292497
[TBL] [Abstract][Full Text] [Related]
27. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis.
Goldman SC; Holcenberg JS; Finklestein JZ; Hutchinson R; Kreissman S; Johnson FL; Tou C; Harvey E; Morris E; Cairo MS
Blood; 2001 May; 97(10):2998-3003. PubMed ID: 11342423
[TBL] [Abstract][Full Text] [Related]
28. Carfilzomib-associated tumor lysis syndrome.
Shely RN; Ratliff PD
Pharmacotherapy; 2014 May; 34(5):e34-7. PubMed ID: 24390940
[TBL] [Abstract][Full Text] [Related]
29. Rasburicase: a new approach for preventing and/or treating tumor lysis syndrome.
Bessmertny O; Robitaille LM; Cairo MS
Curr Pharm Des; 2005; 11(32):4177-85. PubMed ID: 16375739
[TBL] [Abstract][Full Text] [Related]
30. Acute spontaneous tumor lysis syndrome in a patient with Crohn's disease taking immunosuppressants.
Froilán Torres C; Castro Carbajo P; Pajares Villarroya R; Plaza Santos R; Gómez Senent S; Martín Arranz MD; Adán Merino L; Martín Arranz E; Manceñido Marcos N; Peces R; Benito López D
Rev Esp Enferm Dig; 2009 Apr; 101(4):288-94. PubMed ID: 19492906
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis Syndrome.
Philips A; Radhakrishnan V; Ganesan P; Ganesan TS; Ramamurthy J; Dhanushkodi M; Sagar TG
Indian J Hematol Blood Transfus; 2018 Oct; 34(4):618-622. PubMed ID: 30369730
[TBL] [Abstract][Full Text] [Related]
32. A Clinical and Economic Comparison of Rasburicase and Allopurinol in the Treatment of Patients With Clinical or Laboratory Tumor Lysis Syndrome.
Cairo MS; Thompson S; Tangirala K; Eaddy MT
Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):173-178. PubMed ID: 27965022
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous Tumour Lysis Syndrome in Mantle Cell Lymphoma: A Case Study.
Taha N; Bhaskar G
Cureus; 2022 Oct; 14(10):e29851. PubMed ID: 36212272
[TBL] [Abstract][Full Text] [Related]
34. Management of pediatric tumor lysis syndrome.
Tazi I; Nafl H; Elhoudzi J; Mahmal L; Harif M
Arab J Nephrol Transplant; 2011 Sep; 4(3):147-54. PubMed ID: 22026339
[TBL] [Abstract][Full Text] [Related]
35. Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.
Bosly A; Sonet A; Pinkerton CR; McCowage G; Bron D; Sanz MA; Van den Berg H
Cancer; 2003 Sep; 98(5):1048-54. PubMed ID: 12942574
[TBL] [Abstract][Full Text] [Related]
36. Clinical Interventions to Prevent Tumour Lysis Syndrome in Hematologic Malignancy: A Multisite Retrospective Chart Review.
McKenna S; Cheung A; Wolfe A; Coleman BL; Detsky ME; Munshi L; Maze D; Burry L
Can J Hosp Pharm; 2019; 72(6):435-445. PubMed ID: 31853144
[TBL] [Abstract][Full Text] [Related]
37. Emergencies in haematology: tumour lysis syndrome.
Durani U; Hogan WJ
Br J Haematol; 2020 Feb; 188(4):494-500. PubMed ID: 31774551
[TBL] [Abstract][Full Text] [Related]
38. Metastatic gestational trophoblastic neoplasia complicated by tumor lysis syndrome, heart failure, and thyrotoxicosis: a case report.
Schuman S; Pearson JM; Lucci JA; Twiggs LB
J Reprod Med; 2010; 55(9-10):441-4. PubMed ID: 21043373
[TBL] [Abstract][Full Text] [Related]
39. [Tumor lysis syndrome].
Hagino T
Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
[TBL] [Abstract][Full Text] [Related]
40. Reduced administration of rasburicase for tumor lysis syndrome: A single-institution experience.
Takai M; Yamauchi T; Matsuda Y; Tai K; Ikegaya S; Kishi S; Urasaki Y; Yoshida A; Iwasaki H; Ueda T
Oncol Lett; 2015 May; 9(5):2119-2125. PubMed ID: 26137024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
